Drug Trial Radar · NCT07288320
An Assessment of Efficacy, Safety, and Pharmacokinetics of NBI-1117568 in Adults With Bipolar I Disorder With Current Mania
Last checked: Nov 20, 2026Latest source record: Sep 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
150
Planned (sponsor's estimate)
Start
Dec 24, 2025
Primary completion
Feb 2028
Study completion Feb 2028
Sponsor
- Lead sponsor
- Neurocrine BiosciencesNeurocrine Biosciences (NBIX)
- Sponsor type
- Industry
- First posted
- Dec 17, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective for this study is to evaluate the efficacy of NBI-1117568 compared with placebo on improving manic symptoms in adults with bipolar I disorder who are currently experiencing an episode of mania with or without mixed features.
Conditions
- Bipolar I Disorder
- Mania
Interventions
NBI-1117568Drug
Oral administration
PlaceboDrug
Oral administration
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in Young Mania Rating Scale (YMRS) Total Score at Day 21Time frame: Baseline, Day 21
Locations
11 sites in 1 country. Site status is shown where the registry gives one.
Neurocrine Clinical Site
Little Rock, Arkansas · Recruiting
Neurocrine Clinical Site
Cerritos, California · Recruiting
Neurocrine Clinical Site
Garden Grove, California · Recruiting
Neurocrine Clinical Site
San Diego, California · Recruiting
Neurocrine Clinical Site
Hollywood, Florida · Recruiting
Neurocrine Clinical Site
Atlanta, Georgia · Recruiting
Neurocrine Clinical Site
Gaithersburg, Maryland · Recruiting
Neurocrine Clinical Site
Marlton, New Jersey · Recruiting
Neurocrine Clinical Site
Staten Island, New York · Recruiting
Neurocrine Clinical Site
Austin, Texas · Recruiting
Neurocrine Clinical Site
Houston, Texas · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.